Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S38, 2019. DOI: 10.25251/skin.3.supp.38. Disponível em: https://skin.dermsquared.com/skin/article/view/765. Acesso em: 19 apr. 2025.